Fish or shellfish consumption could help patients with AMD

Article

A recent study has revealed that higher consumption of fish or shellfish could help to protect eyes against advanced age-related macular degeneration (AMD).

A recent study has revealed that higher consumption of fish or shellfish could help to protect eyes against advanced age-related macular degeneration (AMD). The data has been published in a recent issue of Ophthalmology.

The research, led by Dr Bonnielin K. Swenor from the Wilmer Eye Institute, Johns Hopkins University, Maryland, USA, explored the relationship between fish and shellfish consumption and AMD status in eyes of participants from the Salisbury Eye Evaluation (SEE) Study.

To estimate the level of weekly fish/shellfish consumption, each patient filled out a food frequency questionnaire. The AMD status was determined from fundus photographs obtained at baseline and graded by 2 masked readers for drusen size, retinal pigment epithelium abnormalities, geographic atrophy (GA) and choroidal neovascularization (CNV). The researchers investigated the association between weekly fish/shellfish consumption and the risk of AMD using logistic regression but adjusted for risk factors and correlation between eyes.

The results demonstrated that there was no difference in the distribution of weekly fish/shellfish consumption between specific AMD categories in comparison with controls. In patients with advanced AMD there was less likelihood of them consuming fish/shellfish that were high in omega-3 fatty acids. Additionally, no relationship was found of AMD with the intake of crab and oysters combined, each of which has high levels of zinc.

From the results the researchers concluded that a protective effect of fish/shellfish intake against advanced AMD was supported.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.